Add BrightSurf on Google Email

New brain mapping reveals unknown cell types

Scientists at Karolinska Institutet have created a detailed map of cortical cell types and the genes active within them using single-cell sequencing. They identified 47 different kinds of cells, including hitherto unknown types, which can help shed more light on diseases like multiple sclerosis.

SourceKarolinska Institutet·JournalScience·DateFeb 19, 2015

Finding turns neuroanatomy on its head

A new study by Harvard neuroscientists reveals that myelin, the electrical insulating material in nerve cells, is not uniformly distributed along axons. Instead, more evolved neurons in the cerebral cortex have intermittent myelin patterns, which may enable increased neuronal communication and complex behavior.

SourceHarvard University·JournalScience·DateApr 18, 2014

Unhealthy attachments

The study used atomic force microscopy and surface forces apparatus to measure the strength of adhesion between healthy and diseased myelin bilayers. Researchers found that healthy myelin adsorbs proteins better, maintaining optimal insulation and nerve function.

SourceUniversity of California - Santa Barbara·JournalProceedings of the National Academy of Sciences·DateFeb 25, 2014

MRI method for measuring MS progression validated

A new MRI approach called quantitative susceptibility mapping (QSM) has been validated for measuring Multiple Sclerosis (MS) progression. QSM provides a quantitative way to measure myelin content and iron deposition in the brain, which are important factors in MS physiology. The study demonstrated that using the correct model can separ...

SourceUniversity of Western Ontario·JournalProceedings of the National Academy of Sciences·DateDec 19, 2013

MS research could help repair damage affecting nerves

A study published in Nature Neuroscience has identified a compound called activin-A that helps trigger the regeneration of protective sheaths around nerve fibers in the brain. This finding could lead to new drug targets for enhancing myelin regeneration and restoring lost function in patients with multiple sclerosis.

SourceUniversity of Edinburgh·JournalNature Neuroscience·DateJul 21, 2013

Big multiple sclerosis breakthrough

A phase 1 clinical trial shows a new treatment safely reduces immune system reactivity to myelin in multiple sclerosis patients by 50-75%. The therapy, which uses specially processed white blood cells, preserves the function of the normal immune system. Researchers hope to launch a phase 2 trial to prevent MS progression.

SourceNorthwestern University·JournalScience Translational Medicine·DateJun 5, 2013

Hitting 'reset' in protein synthesis restores myelination

Researchers at UB's Hunter James Kelly Research Institute have found that reducing a protein called Gadd34 can improve nerve and muscle function in patients with CMT neuropathies. By leaving protein synthesis partially off, they were able to restore myelination, potentially leading to new treatments for other misfolded protein diseases.

SourceUniversity at Buffalo·JournalJournal of Experimental Medicine·DateApr 26, 2013

Changes in nerve cells may contribute to the development of mental illness

A study published in Nature Neuroscience reveals that social isolation can reduce myelin production in mice, affecting the formation of new oligodendrocytes and leading to behavioral changes. Reintroduction into a social group reverses these effects, suggesting environmental factors play a crucial role in maintaining healthy nerve cells.

Research breakthrough selectively represses the immune system

Researchers have developed a novel treatment that selectively inhibits the part of the immune system responsible for attacking myelin, reducing inflammation in autoimmune disorders like MS. The therapy uses microscopic particles to induce tolerance in animal models, showing potential for treating MS, type I diabetes, and food allergies.

Human neural stem cells study offers new hope for children with fatal brain diseases

Researchers at Oregon Health & Science University have demonstrated that banked human neural stem cells can survive and make functional myelin in mice with severe symptoms of myelin loss. The study provides proof of principle for treating a wide variety of disorders that affect myelin, including cerebral palsy and multiple sclerosis.

SourceOregon Health & Science University·JournalScience Translational Medicine·DateOct 10, 2012

PRB at Wayne State/DMC discover window of opportunity to prevent cerebral palsy

A new study published in Science Translational Medicine suggests that an anti-inflammatory drug delivered via a nanodevice can improve CP symptoms in animal models. The findings indicate a window of opportunity for postnatal treatment to prevent the condition, with potential implications for future treatments of neurological disorders.

Study finds age-related effects in MS may be reversible

A study published in Cell Stem Cell found that defects in myelin sheath regeneration surrounding nerves can be at least partially corrected following exposure to young immune cells. This suggests that regenerative therapies may work throughout the duration of MS, regardless of age. The findings provide new hope for treating this disease.

SourceJoslin Diabetes Center·JournalCell Stem Cell·DateJan 6, 2012

New imaging technique evaluates nerve damage

A new imaging technique allows researchers to assess nerve damage and healing in live patients, providing a non-invasive method for diagnosing nerve injuries. The technique uses lasers to create images of individual neurons' insulating sheaths, revealing the extent of myelin loss and recovery.

SourceOptica·JournalBiomedical Optics Express·DateSep 13, 2011

MS research: Myelin influences how brain cells send signals

Researchers at Ohio State University have developed a cell-culture system that mimics the coating of nerve cells with protective myelin, opening up new possibilities for studying multiple sclerosis. The study found that myelin regulates key protein placement and activity in sending electrical signals along hippocampal axons.

SourceOhio State University·JournalJournal of Biological Chemistry·DateJul 21, 2011